EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cell Communication Network factor 4 promotes tumor-induced immunosuppression in breast cancer

David J Klinke iD, Atefeh Razazan, Anika C Pirkey, Wentao Deng

Disease Models & Mechanisms · 16.11.2026

DOI: 10.1242/dmm.052863 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, online erschienen am 16.11.2026. Verfasst von David J Klinke und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomedical Engineering, West Virginia University, Morgantown, WV, USA. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, U.S. National Science Foundation, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cell Communication Network factor 4 (CCN4/WISP1) is a matricellular protein secreted by cancer cells that is upregulated in essentially all invasive breast cancers and promotes immunosuppression in melanoma. Limited anti-tumor immunity associates with poor patient outcomes in breast cancer, and elevated CCN4 correlates with dampened anti-tumor immunity in primary breast cancer tumors. To test for a direct causal link, we knocked out CCN4 in the Py230 and Py8119 syngeneic mouse breast cancer models. CCN4 knockout dramatically prolonged tumor-free survival in immunocompetent but not immunodeficient mice, establishing that CCN4's tumor-promoting effects are immune-dependent. In size-matched tumors, CCN4 knockout increases CD45+ infiltration and shifts the myeloid compartment from polymorphonuclear- to monocytic-myeloid-derived suppressor cells (MDSCs), changes accompanied by a significant reduction in splenomegaly consistent with a systemic as well as local effect. CCN4 knockout produces convergent secretome changes across both breast cancer and melanoma cell lines, pointing to a conserved immunosuppressive program. Analysis of TCGA breast cancer data further reveals that genetic alterations converging on beta-catenin pathway activation, including CCN4 copy number amplification at a frequency comparable to ERBB2, are present in a substantial fraction of invasive breast cancers. Together, these findings establish CCN4 as a driver of tumor-induced immunosuppression in breast cancer and a promising target for combination with existing immunotherapies.

Schlagwörter

Stichwörter der Autor:innen

Breast cancerCCN4/WISP1Epithelial-mesenchymal transitionMyeloid-derived suppressor cellsTumor-induced immunosuppression

Autor:innen und Institutionen

  • Department of Chemical and Biomedical Engineering, West Virginia University, Morgantown, WV, USA.
  • Department of Physiology, Pharmacology and Toxicology, West Virginia University, Morgantown, WV, USA.

ORCID-Profile: David J Klinke

Förderung

  • NCI NIH HHS
  • U.S. National Science Foundation
  • National Cancer Institute

Zitieren

APA

Klinke, D. J., Razazan, A., Pirkey, A. C., & Deng, W. (2026). Cell Communication Network factor 4 promotes tumor-induced immunosuppression in breast cancer. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052863

Vancouver

Klinke DJ, Razazan A, Pirkey AC, Deng W. Cell Communication Network factor 4 promotes tumor-induced immunosuppression in breast cancer. Disease Models & Mechanisms. 2026. doi:10.1242/dmm.052863

BibTeX
@article{Klinke2026,
  author = {Klinke, David J and Razazan, Atefeh and Pirkey, Anika C and Deng, Wentao},
  title = {Cell Communication Network factor 4 promotes tumor-induced immunosuppression in breast cancer},
  journal = {Disease Models & Mechanisms},
  year = {2026},
  doi = {10.1242/dmm.052863}
}
Kostenlos starten →